Anti-HER2 Monoclonal Antibody(Pertuzumab) Size:10mg often as a consequence of

often as a consequence of gene amplification

with C-terminal 10*His LEEVLLDTTGETSEIGWLTYPPGGWDEVSVLDDQRRLTRTFEACHVAGAPPGTGQDNWLQTHFVERRGAQRAHIRLHFSVRACSSLGVSGGTCRETFTLYYRQAEEPDSPDSVSSWHLKRWTKVDTIAADESFPSSSSSSSSSSSAAWAVGPHGAGQRAGLQLNVKERSFGPLTQRGFYVAFQDTGACLALVAVRLFSYTCPAVLRSFASFPETQASGAGGASLVAAVGTCVAHAEPEEDGVGGQAGGSPPRLHCNGEGKWMVAVGGCRCQPGYQPARGDKACQACPRGLYKSSAGNAPCSPCPARSHAPNPAAPVCPCLEGFYRASSDPPEAPCTGPPSAPQELWFEVQGSALMLHWRLPRELGGRGDLLFNVVCKECEGRQEPASGGGGTCHRCRDEVHFDPRQRGLTESRVLVGGLRAHVPYILEVQAVNGVSELSPDPPQAAAINVSTSHEVPSAVPVVHQVSRASNSITVSWPQPDQTNGNILDYQLRYYDQAEDESHSFTLTSETNTATVTQLSPGHIYGFQVRARTAAGHGPYGGKVYFQTLPQGELSSQLPERLSGGGSGGGSHHHHHHHHHH

IgG4 and IgG2

streptomycin

Anti-HER2 Monoclonal Antibody(Pertuzumab) Size:10mg often as a consequence ofProduct Specification Host Human Synonyms Receptor tyrosine protein kinase erbB 2, Metastatic lymph node gene 19 protein (MLN 19), Proto oncogene Neu, Proto oncogene c ErbB 2, Tyrosine kinase type cell surface receptor HER2, p185erbB2, CD340, ERBB2, MLN19, NEU, NGL Accession P04626 Clone Number S SC018 Antibody Type Recombinant mAb Isotype IgG1,k Application Blocking of HER2 signaling Functional assays Purification Protein A Concentration 2 mg ml